Bloomios Inc BLMS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.84
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $77,367.90
- Volume/Avg
- 40,000 / 645,567
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.00
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- https://www.bloomios.com
Valuation
|
Metric
|
BLMS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.00 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BLMS
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −13.15 |
Quick Ratio
BLMS
Profitability
|
Metric
|
BLMS
|
|---|---|
Return on Assets (Normalized) | −82.86% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −104.90% |
Return on Assets
BLMS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xfyczpgjc | Plbv | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Wsbgxfpsnv | Frlsz | $68.1 Bil | |
HLN
| Haleon PLC ADR | Jvylhzdt | Swybg | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yzmtwplrk | Wscxx | $14.3 Bil | |
VTRS
| Viatris Inc | Pgpylwmzy | Zft | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Dclwbchm | Mblw | $11.9 Bil | |
CTLT
| Catalent Inc | Nvmkvxq | Hdtsfl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mkbjnggk | Dsqwr | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bnqckglx | Ycbk | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gmrpvsjt | Vjmvl | $3.4 Bil |